WBA240920P14000
- 4.91
- 0.000.00%
Walgreens Boots Alliance Newsroom
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
3 Reasons Why Walgreens Boots Alliance Stock May Not Be Doomed
CVS Subsidiary Oak Street Health Agrees to $60M Settlement in Medicare Kickback Violations
Freight crisis on the east coast of the USA! Dock workers may go on strike in October to protest.
①The United States is currently holding elections, and just started a rate cut cycle on Wednesday. At this time, any movement in the economy could become a major challenge. ②Dock workers on the East Coast of the United States have warned that if a new labor agreement is not reached by the end of this month, they will go on strike starting from October 1st. ③This will have a serious impact on the retail trade in the United States, and may even disrupt the downward trend in inflation.
Walgreens Boots Alliance (WBA) Suffers a Larger Drop Than the General Market: Key Insights
Cencora Cut to Neutral at BofA; Risks to Walgreens, Cigna Contracts Cited
UBS Highlights 30 Stocks Poised for Potential Moves After the Fed's Expected Rate Cut
Pockets of Strength in the Retail Sales Report Included Personal Care, E-commerce, and Electronics,
Wall Street's Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 7% Dividend Yields
Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims
Short Bets for Consumer Staples Rise in August Across Industries
Express News | Walgreens Stores Will Close for Thanksgiving Holiday
Looking Into Walgreens Boots Alliance's Recent Short Interest
Is Walgreens Boots Alliance Stock a Buy?
Goldman Thinks Walgreens Boots Alliance, Inc. (WBA) Is A Long-Term AI Stock Set To Rally Eventually
Most Shorted S&P 500 Stocks in August
Barclays Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Barclays analyst Stephanie Davis maintains $Walgreens Boots Alliance(WBA.US)$ with a sell rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 41.
Walgreens Boots Alliance: Liquidity Concerns Sustain Sell Rating
Chain pharmacy Walgreens has agreed to pay approximately $0.1 billion to settle a prescription drug fraud investigation.
On September 14th, Gelunge reported that Walgreens Boots Alliance, a chain pharmacy in the United States, has agreed to pay approximately $0.11 billion to settle allegations by the U.S. government that it charged fraudulent fees for prescription drugs that were never dispensed. According to the Department of Justice, Walgreens submitted claims for payment for certain prescription drugs to Medicare, Medicaid, and other medical care programs between 2009 and 2020, but these prescriptions were never picked up or used by customers, in violation of the U.S. Federal False Claims Act. The Department stated that Walgreens will...
Correction to Walgreens to Pay Over Alleged Fraudulent Billings Article